Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01494051
Other study ID # DK71869-2
Secondary ID
Status Completed
Phase Phase 1/Phase 2
First received
Last updated
Start date January 2006
Est. completion date January 2010

Study information

Verified date April 2020
Source Oregon Health and Science University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study also determines if eating a diet higher in protein alters body composition, energy balance and metabolic control among patients with a long-chain fatty acid oxidation disorder.


Description:

At baseline, the amount of muscle and fat in the whole body and inside the liver and muscle will be measured. All subjects will complete a moderate treadmill exercise test and a test to determine how they use sugar (oral glucose tolerance test). The amount and type of energy burned by each subject will be measured. Subjects will be randomly assigned to follow either a high carbohydrate diet or a reduced carbohydrate, high protein diet for 4 months. At the end of 4 months, the tests will be repeated.


Recruitment information / eligibility

Status Completed
Enrollment 13
Est. completion date January 2010
Est. primary completion date September 2009
Accepts healthy volunteers No
Gender All
Age group 7 Years to 45 Years
Eligibility Inclusion Criteria:

- diagnosis of a long-chain fatty acid oxidation disorder including VLCAD, CPT2, LCHAD or TFP deficiency

- 7 years old or greater

- able to comply with diet guidelines

Exclusion Criteria:

- pregnant

- enrolled in another study that alters diet composition

- cannot complete treadmill exercise study

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Diet counseling
Subjects counseled how to follow either the high carbohydrate diet or the high protein diet for 4 months at home.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Oregon Health and Science University

Outcome

Type Measure Description Time frame Safety issue
Primary Energy Expenditure does energy expenditure and substrate oxidation differ between subjects randomized to the high carbohydrate versus the high protein diet? We measured resting energy expenditure with indirect calorimetry and estimated substrate oxidation with indirect calorimetry results and urine urea nitrogen excretion. We also measured total energy expenditure with doubly labeled water. change from baseline after 4 months of treatment
Secondary Body Composition does body composition change more among subjects randomized to the high protein diet compared to the high carbohydrate diet? We measured body composition at baseline and again at the end of the study by DEXA - dual energy x-ray absorptiometry. change from baseline to 4 months of treatment
See also
  Status Clinical Trial Phase
Recruiting NCT05687474 - Baby Detect : Genomic Newborn Screening
Recruiting NCT05910151 - Selective Screening of Children for Hereditary Metabolic Diseases by Tandem Mass Spectrometry in Kazakhstan
Enrolling by invitation NCT03655223 - Early Check: Expanded Screening in Newborns
Active, not recruiting NCT02635269 - Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy N/A
Completed NCT02517307 - Fatty Acid Oxidation Defects and Insulin Sensitivity N/A
Completed NCT05411835 - Oral Ketones and Exercise Among Patients With Long-chain Fatty Acid Oxidation Disorders Early Phase 1